SCHEMBL268013

SCHEMBL268013

CC[C@@H](CN)CC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2633043 1.00
SCHEMBL24880069 1.00
SCHEMBL964997 0.84 CACNA2D1 (0.56)
SCHEMBL13286712 0.84 ALDH1A1 (0.52)
SCHEMBL28211141 0.81 ALDH1A1 (0.50)
SCHEMBL9945578 0.81 ALDH1A1 (0.50)
SCHEMBL4652961 0.81 TSHR (0.39)
SCHEMBL597708 0.81
SCHEMBL8171725 0.80
SCHEMBL5608034 0.80 ALDH1A1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022120475-A1 3-CYCLIC AMINE-INDOLE DERIVATIVES AS SEROTONERGIC AGENTS FOR THE TREATMENT OF CNS DISORDERS MINDSET PHARMA INC. (CA) 2022-06-16 WO disclosed
WO-2021155467-A1 3-PYRROLIDINE-INDOLE DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS MINDSET PHARMA INC. (CA) 2021-08-12 WO disclosed
EP-3761036-A1 PREGABALIN IMMUNOASSAYS ARK Diagnostics, Inc. (US) 2021-01-06 EP disclosed
EP-3265074-B1 PREGABALIN IMMUNOASSAYS ARK DIAGNOSTICS INC (US) 2020-08-12 EP disclosed
US-10023885-B2 Process for the preparation of pregabalin HIKAL LIMITED (IN) 2018-07-17 US disclosed
US-9745249-B2 Method for the preparation of beta-substituted gamma-amino carboxylic acids SIEGFRIED LTD. (CH) 2017-08-29 US disclosed
WO-2017133517-A1 PHOSPHAMIDE DERIVATIVE, METHOD FOR MANUFACTURING THE SAME, AND USES THEREOF 四川海思科制药有限公司 2017-08-10 WO disclosed
US-20170114003-A1 METHOD FOR THE PREPARATION OF BETA-SUBSTITUTED GAMMA-AMINO CARBOXYLIC ACIDS SIEGFRIED LTD. (CH) 2017-04-27 US disclosed
US-20150344919-A1 PROCESS FOR THE PREPARATION OF PREGABALIN HIKAL LIMITED (IN) 2015-12-03 US disclosed
US-8134023-B2 Preparation of pregabalin and related compounds PFIZER INC (US) 2012-03-13 US disclosed
US-20110065168-A1 Preparation of Pregabalin and Related Compounds PFIZER INC 2011-03-17 US disclosed
WO-2010115612-A2 PREGABALIN COMPOSITIONS SYNTHON B.V. (NL) 2010-10-14 WO disclosed
US-7763749-B2 Method for the preparation of Pregabalin and salts thereof TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2010-07-27 US disclosed
US-20090312560-A1 PROCESSES FOR MAKING PREGABALIN AND INTERMEDIATES THEREFOR SYNTHON BV (NL) 2009-12-17 US disclosed
EP-1745136-B1 METHOD FOR ENZYMATIC PREPARATION OF (S)-3-CYANO-5-METHYLHEXANOIC ACID PFIZER PROD INC (US) 2009-10-07 EP disclosed
WO-2009087674-A2 IMPROVED PROCESS FOR THE PREPARATION OF (S)-PREGABALIN Watson Pharma Private Limited (IN) 2009-07-16 WO disclosed
US-20080188562-A1 1-{[ alpha -isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane acetic acid and 3-{[( alpha -isobutanoyloxyethoxy)carbonyl]aminomethyl}-5-methyl hexanoic acid; extended oral release dosage form with a reduced rate of systemic clearance and without significant side effects XENOPORT, INC. 2008-08-07 US disclosed
US-20070073085-A1 Method for the preparation of pregabalin and salts thereof TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2007-03-29 US disclosed
WO-2006122258-A1 METHOD FOR THE PREPARATION OF PREGABALIN AND SALTS THEREOF TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2006-11-16 WO disclosed
WO-2006110783-A2 PROCESS FOR MAKING (S)-PREGABALIN TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2006-10-19 WO disclosed